- Home
- TXMD vs SFHG Comparison
TXMD vs SFHG Comparison
Compare TXMD & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- SFHG
- Stock Information
- Founded
- TXMD 2008
- SFHG 1993
- Country
- TXMD United States
- SFHG Hong Kong
- Employees
- TXMD N/A
- SFHG N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- SFHG Publishing
- Sector
- TXMD Health Care
- SFHG Consumer Discretionary
- Exchange
- TXMD Nasdaq
- SFHG Nasdaq
- Market Cap
- TXMD 17.1M
- SFHG 16.2M
- IPO Year
- TXMD N/A
- SFHG 2024
- Fundamental
- Price
- TXMD $1.09
- SFHG $0.68
- Analyst Decision
- TXMD
- SFHG
- Analyst Count
- TXMD 0
- SFHG 0
- Target Price
- TXMD N/A
- SFHG N/A
- AVG Volume (30 Days)
- TXMD 66.5K
- SFHG 48.2K
- Earning Date
- TXMD 08-11-2025
- SFHG 07-07-2025
- Dividend Yield
- TXMD N/A
- SFHG N/A
- EPS Growth
- TXMD N/A
- SFHG N/A
- EPS
- TXMD N/A
- SFHG N/A
- Revenue
- TXMD $1,841,000.00
- SFHG $19,760,935.00
- Revenue This Year
- TXMD $427.09
- SFHG N/A
- Revenue Next Year
- TXMD N/A
- SFHG N/A
- P/E Ratio
- TXMD N/A
- SFHG N/A
- Revenue Growth
- TXMD 53.55
- SFHG 30.89
- 52 Week Low
- TXMD $0.70
- SFHG $0.55
- 52 Week High
- TXMD $2.44
- SFHG $24.00
- Technical
- Relative Strength Index (RSI)
- TXMD 38.09
- SFHG N/A
- Support Level
- TXMD $1.07
- SFHG N/A
- Resistance Level
- TXMD $1.22
- SFHG N/A
- Average True Range (ATR)
- TXMD 0.13
- SFHG 0.00
- MACD
- TXMD -0.02
- SFHG 0.00
- Stochastic Oscillator
- TXMD 19.15
- SFHG 0.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.